<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">As transmission between humans mainly occurs within healthcare environments, Emmie de Wit and colleagues at the National Institute of Allergy and Infectious Diseases at Hamilton, USA, have tested the prophylactic use of the antiviral drug remdesivir (Proc. Natl. Acad. Sci. USA (2020) 
 <italic>117</italic>, 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1922083117" id="intref0010" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.1073/pnas.1922083117</ext-link>). In a study using rhesus macaques, the researchers found that the compound, if given before infection with the virus, protects the animals from becoming ill. The researchers conclude that its usefulness for the protection of healthcare professionals in the current coronavirus outbreak should be tested.
</p>
